SuspendedNot Applicable

Intelligent Monitoring to Predict Atrial Fibrillation

Stopped: logistical issues

United Kingdom1,200 participantsStarted 2024-09-23

Plain-language summary

Atrial Fibrillation (AF) is the commonest arrhythmia worldwide, affects 5% of people over the age of 65 and increases the risk of stroke and heart failure. The investigators aim to detect clinical and subclinical episodes of atrial fibrillation lasting \&amp;gt;30 seconds to develop risk prediction models to identify patients at high risk for ischaemic stroke.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients ≥50 years * Estimated risk of developing new episodes of AF greater than 5% * Sinus rhythm at presentation * One of the following acute conditions: * Patients admitted or referred to Critical Care (NOTE-AF ICU) * Patients admitted to hospital with acute heart failure (NOTE-AF HF) * Patients admitted to Emergency Services with sepsis or infection (NOTE-AF Sepsis) * Patients post upper gastrointestinal surgery (NOTE-AF PULSE-GI) * Patients post vascular interventions (NOTE-AF Vasc) * Patients with acute respiratory failure (NOTE-AF Resp) * Patients admitted after acute stroke (NOTE-AF stroke) Exclusion Criteria: * Atrial fibrillation or atrial flutter at the time of screening * Patients in atrial fibrillation or atrial flutter at time of preoperative assessment or admission to hospital * Paced cardiac rhythm * Inability to obtain consent * Allergy to plaster or silicone * Expected hospital stay less than 48 hours

What they're measuring

To determine the incidence of clinical and subclinical episodes of AF in acutely unwell patients and to generate data for the development and validation of virtual twins and clinical decision support tools.

Timeframe: 48 months

Trial details

NCT IDNCT06600620

SponsorLiverpool University Hospitals NHS Foundation Trust

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2028-07-31

View on ClinicalTrials.gov More Atrial Fibrillation New Onset trials